How do you regulate something you cannot define? It’s a dilemma that policymakers around the world are struggling with as they try to enact regulations for nanomaterials—that loosely defined group of very small particles with very large implications and applications for everything from self-cleaning windows and mirrors, to better renewable energy materials, to more precise and effective cancer treatments. Yet, the same properties of nanomaterials that enable these beneficial applications, including small size and increased reactivity, may also make these same materials more dangerous inside our bodies or in the environment.
But to enact and enforce rules on this miniscule scale, regulators first need to come up with a definition of nanomaterials that is both legally precise and scientifically sound. And, as nano expert Andrew Maynard put it in Nature in 2011, “a sensible definition has proved hard, if not impossible, to arrive at.” (Maynard is my colleague at Arizona State University; ASU is a partner with Slate and New America in Future Tense.)
Consider two recent attempts. Exhibit A is the definition of nanotechnology adopted by the European Union. After much deliberation and struggle, in 2011 the European Commission, which aimed to adopt a “science-based” definition, came up with the following:
A natural, incidental or manufactured material containing particles, in an unbound state or as an aggregate or as an agglomerate and where, for 50% or more of the particles in the number size distribution, one or more external dimensions is in the size range 1 nm [nanometer] - 100 nm. In specific cases and where warranted by concerns for the environment, health, safety or competitiveness the number size distribution threshold of 50% may be replaced by a threshold between 1 and 50%.
Exhibit B is the U.S. Environmental Protection Agency’s proposed definition of nanomaterials. The regulatory body is scheduled to finalize rules this fall requiring companies that produce or handle nanomaterials to report certain information about such substances to the agency:
[A] chemical substance that is solid at 25 °C and atmospheric pressure that is manufactured or processed in a form where the primary particles, aggregates, or agglomerates are in the size range of 1–100 nm and exhibit unique and novel characteristics or properties because of their size. A reportable chemical substance does not include a chemical substance that only has trace amounts of primary particles, aggregates, or agglomerates in the size range of 1–100 nm, such that the chemical substance does not exhibit the unique and novel characteristics or properties because of particle size.
See the differences? The EPA definition only includes manufactured nanomaterials, but the EU definition includes manufactured, natural, and incidental ones. On the other hand, the EPA defines materials by size (1–100nm) and requires that they exhibit some novel property (like catalytic activity, chemical reactivity, or electric conductivity), while the EU just looks at size. And it goes on with differences in composition requirements, aggregate thresholds, and other characteristics.
These are just two of more than two dozen regulatory definitions of nanotechnology, all differing in important ways: size limits, dimensions (do we regulate in 1-D, 2-D, or 3-D?), properties, etc. These differences can have major practical significance—for example, some commercially important materials (e.g., graphite sheets) may be nanosize in one or two dimensions but not three. The conflicting definitions create confusion and inefficiencies for consumers, companies, and researchers when some substances are defined as nanomaterials under certain programs or nations but not others.
But there’s an even bigger problem than the jumble of terms: None of the definitions are actually workable. Nanotechnology encompasses a very broad range of materials, products, and applications that involve unique properties at small sizes. There is no magical size cutoff that applies across all of the various types of nanomaterials. For example, many nanomaterials exhibit unique nano properties only at sizes below 30 nm, while other materials exhibit unique properties in particles above 100 nm. Thus, it makes no scientific sense to say that a particle of a given type is nanotechnology if it is 95 nm in diameter but not if it is 105 nm.
Similarly, there is no magic composition cutoff that easily establishes that a product should be considered “nano.” Is it when more than half of the material is in the specified size range? 100 percent of material? 10 percent? 1 percent? “Trace amounts”? And if we set such an arbitrary limit, won’t it cause enormous confusion and compliance problems when the makeup of materials differs based on slight production variations, natural environmental fluctuations, or companies who manipulate products to be just under the set threshold? And how will we even test this? Measuring the percentage of particles in a product that are between 1–100 nm in size is a very expensive and complex undertaking and currently technically infeasible for many materials.
Beyond that, many materials that happen to fall in the size and composition range laid out by these regulatory definitions don’t exhibit characteristic properties of nanomaterials that raise red flags of potential hazard. For example, gold nanoparticles less than 3 nm exhibit strong catalytic activity for certain reactions, whereas larger gold particles are inert. Only the former are likely to be potentially dangerous. Because of this, most scientists recommend that regulatory definitions include requirements related to both size and potential significance. Otherwise, they risk being ridiculously overinclusive. Take, for example, the definition put forward by the EPA. Although it does include a caveat about regulated nanomaterials needing “novel characteristics,” it doesn’t actually lay out criteria of what constitutes “novel.” Does a different color at the nanoscale count? What about increased electrical conductivity? With these kinds of ambiguities, the reporting requirements the EPA is pushing become impossible to enforce.
So what are policymakers to do when they can’t even properly define what they’re trying to regulate? Some experts advocate developing even more detailed criteria that encompass these concerns, but there remains the question of whether the standards will be administratively feasible to test. Others suggest defining and regulating only specific nanostructures—such as commercially important and well-characterized nanomaterials like carbon nanotubes and quantum dots—rather than trying to devise a catchall definition. But then regulators risk falling behind in a fast-paced industry in which new forms and structures of nanomaterials are constantly being developed, sticking to substances that have been around longer at the danger of missing the new ones we need to be most concerned about.
Perhaps the most feasible approach is to forget about developing nanospecific regulations altogether and instead put in place regulatory programs that consistently screen all new materials for safety, whether or not they meet an arbitrary definition of “nanomaterials.” The European REACH program and the recently revised U.S. Toxic Substances Control Act have both made moves in this direction, and may save us from such futile definitions. In the absence of a legally precise definition of nanotechnology, and given that all products include some nanosize particles, current efforts to enact nanospecific regulations may be misdirected. We might be better off devoting scarce regulatory resources to improving regulatory assessment of all materials, whether they contain a little nano or a lot of nano.
This article is part of the nanotechnology installment of Futurography, a series in which Future Tense introduces readers to the technologies that will define tomorrow. Each month, we’ll choose a new technology and break it down. Future Tense is a collaboration among Arizona State University, New America, and Slate.